Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
Abstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2695 |
_version_ | 1818598742759047168 |
---|---|
author | Namrata Singhania Raman Al‐Odat Anil K. Singh Laith Al‐Rabadi |
author_facet | Namrata Singhania Raman Al‐Odat Anil K. Singh Laith Al‐Rabadi |
author_sort | Namrata Singhania |
collection | DOAJ |
description | Abstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition. |
first_indexed | 2024-12-16T12:08:32Z |
format | Article |
id | doaj.art-2e84163f63374de38b2f6e12c0875ba3 |
institution | Directory Open Access Journal |
issn | 2050-0904 |
language | English |
last_indexed | 2024-12-16T12:08:32Z |
publishDate | 2020-04-01 |
publisher | Wiley |
record_format | Article |
series | Clinical Case Reports |
spelling | doaj.art-2e84163f63374de38b2f6e12c0875ba32022-12-21T22:32:15ZengWileyClinical Case Reports2050-09042020-04-018472272410.1002/ccr3.2695Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoalNamrata Singhania0Raman Al‐Odat1Anil K. Singh2Laith Al‐Rabadi3Department of Hospital Medicine Mount Carmel East Hospital Columbus OhioDepartment of Internal Medicine University of New Mexico Albuquerque New MexicoDepartment of Internal Medicine Geisinger Community Medical Center Scranton PennsylvaniaDepartment of Nephrology University of Utah Salt Lake City UtahAbstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.https://doi.org/10.1002/ccr3.2695activated charcoalend‐stage renal diseaseintentional drug overdosekayexalatekidney transplant |
spellingShingle | Namrata Singhania Raman Al‐Odat Anil K. Singh Laith Al‐Rabadi Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal Clinical Case Reports activated charcoal end‐stage renal disease intentional drug overdose kayexalate kidney transplant |
title | Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal |
title_full | Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal |
title_fullStr | Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal |
title_full_unstemmed | Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal |
title_short | Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal |
title_sort | intestinal necrosis after co administration of sodium polystyrene sulfonate and activated charcoal |
topic | activated charcoal end‐stage renal disease intentional drug overdose kayexalate kidney transplant |
url | https://doi.org/10.1002/ccr3.2695 |
work_keys_str_mv | AT namratasinghania intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal AT ramanalodat intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal AT anilksingh intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal AT laithalrabadi intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal |